纳米团簇
纤颤
动态光散射
胶体金
纤维
淀粉样蛋白(真菌学)
淀粉样变性
纳米技术
纳米颗粒
生物物理学
胶束
成核
体内
神经退行性变
材料科学
化学
医学
生物
病理
内科学
水溶液
无机化学
有机化学
物理化学
心房颤动
作者
Guanbin Gao,Mingxi Zhang,Dejun Gong,Rui Chen,Binwu Ying,Taolei Sun
出处
期刊:Nanoscale
[Royal Society of Chemistry]
日期:2017-03-23
卷期号:9 (12): 4107-4113
被引量:103
摘要
A significant pathological signature of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ) plaques in the brain and the synaptic dysfunction and neurodegeneration associated with it. Compounds or drugs that inhibit Aβ fibrillation are thus desirable to develop novel therapeutic strategies against AD. Conventional strategies usually require an elaborate design of their molecular structures. Here we report the size-effect of gold nanoparticles (AuNPs) and nanoclusters (AuNCs) in the inhibition of protein amyloidosis. Using l-glutathione stabilized AuNPs with different sizes and AuNCs as examples, we show that large AuNPs accelerate Aβ fibrillation, whereas small AuNPs significantly suppress this process. More interestingly, AuNCs with smaller sizes can completely inhibit amyloidosis. Dynamic light scattering (DLS) experiments show that AuNCs can efficiently prevent Aβ peptides from aggregation to larger oligomers (e.g. micelles) and thus avoid nucleation to form fibrils. This is crucially important for developing novel AD therapies because oligomers are the main source of Aβ toxicity. This work presents a novel strategy to design anti-amyloidosis drugs, which also provides interesting insights to understand how biological nanostructures participate in vivo in Aβ fibrillation from a new perspective.
科研通智能强力驱动
Strongly Powered by AbleSci AI